Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 237 for “"LNP"”.
-
OVERCOMING BIOLOGICAL BARRIERS TO LNP-MEDIATED DNA DELIVERY
While lipid nanoparticles (LNPs) have enabled the clinical success of RNA therapeutics, their application to DNA delivery remains constrained by innate immune toxicity and inefficient nuclear access. This dissertation elucidates the underlying mechanisms and establishes strategies to overcome these …
-
Evaluating Buffer Concentrations and pH effects on LNP-mRNA stability
… challenges that limit broader application. mRNA-LNP formulations require ultra-cold storage (-60 to -80°C) due to susceptibility to pH-dependent hydrolytic degradation, oxidative damage, and temperature sensitivity. The formulation buffer plays a critical yet underexplored role in maintaining pH …
-
Development of novel PEG-free LNP formulations using sugar-based surfactant
The full abstract for this thesis is available in the body of the thesis, and will be available when the embargo expires.
-
Development of an LNP Formulation for Transfection of Unmodified Primary T Cells
… viral vectors or non-viral lipid nanoparticles (LNPs) has been shown to be effective. LNPs are synthetic charged lipid vesicles that can carry nucleic acids (RNA or DNA) into target cells resulting in transient expression of the therapeutic molecule (details in section 1.1). Since, LNPs can be …
-
Optimization of lipid nanoparticle (LNP) formulation methods and evaluation of the product stability
… to improve their efficacy. Lipid nanoparticles (LNPs) are one of the most popular non-viral mRNA delivery platforms and have been utilized in mRNA COVID-19 vaccines. LNPs are nanostructured carriers with multiple compartments, typically formulated by ionizable cationic lipids, phospholipids, …
-
DEVELOPMENT OF A VACCINE FOR LYME DISEASE USING THE NUCLEOSIDE-MODIFIED mRNA-LNP PLATFORM
… nucleoside-modified mRNA (mRNA-LNP) platform to generate a Lyme disease vaccine like the successful clinical vaccines against SARS-CoV-2. Of the antigens expressed by Borrelia burgdorferi, the causative agent of Lyme disease, outer surface protein A (OspA) is the most promising …
-
Design, Testing, and Optimization of a Preclinical mRNA-LNP Vaccine for Hepatitis C Virus Prophylaxis
… mRNA lipid nanoparticle (mRNA-LNP) vaccine platform. We evaluated structural and nonstructural viral proteins in our vaccine constructs, demonstrating that encoding p7 along with core (C), envelope glycoprotein 1 (E1), and envelope glycoprotein 2 (E2) led to significantly more …
-
AN mRNA-LNP VACCINE ENCODING RECEPTOR-BINDING DOMAIN FRAGMENTS OF TOXIN A AGAINST CLOSTRIDIUM DIFFICILE
Clostridium difficile infection is the major cause of nosocomial diarrhea and colitis in developed countries. The broad use of antibiotics has contributed to the occurrence and spread of antibiotic-resistant C. difficile strains in recent years. The main virulent factors of its pathogenicity are …
-
Optimizing lnp-mediated mrna delivery in induced brain microvascular endothelial cells and a 3d microvessel system
… that target this barrier. Lipid nanoparticles (LNPs) have emerged as a promising delivery platform, yet their performance in BBB-relevant endothelial models remains to be systematically defined. In this study, we established a tissue-engineered in vitro BBB model using induced brain …
-
Process and Formulation Optimization of a Continuous Microfluidic-Based Platform for High-Quality mRNA-LNP Production
Messenger RNA (mRNA) has emerged as a transformative platform for vaccines and targeted therapies due to its capacity for precise and rapid gene expression. The COVID-19 pandemic underscored both its promise and the challenges of large-scale production. In response, continuous flow …
-
Developing the next generation of mRNA vaccines : redefining mRNA delivery through rational LNP manufacturing, formulation and targeting studies
… clinical success during the COVID-19 pandemic, LNPs have lacked in areas such as fast and simple formulation screening, enhanced endosomal escape and extra-hepatic targeting capabilities. Enhanced screening techniques and optimised manufacturing could help alleviate these issues. This thesis …
-
FcγRIIIa Expressing Biomimetic Nanoparticles Harness The Power Of Natural Killer Cells To Target Cancer
… cell membrane integrated lipid nanoparticle (LNP), we termed as CD16NK-LNP, to express FcγRIIIa (commonly known as CD16a). We hypothesized that the expression of CD16a on LNP could enhance antibody-directed binding, targeting and retention of the LNP in tumors that over-express specific …
-
Evaluating the impact of using 300 mM Na-citrate as the pH 4 loading buffer on LNP-mediated base and prime editing efficiency
… available delivery methods, lipid nanoparticles (LNPs) that delivery gene editors in the form of RNA present one of the most appealing options for in vivo use. While LNPs have achieved preclinical successes with in vivo gene editing and are now entering clinical trials, there remains room for …
-
Structural and Functional Insights into Porphyrin Lipid Nanoparticles for RNA Delivery
Lipid nanoparticles (LNPs) have established themselves as the leading delivery platform for RNA therapeutics, exemplified by the clinical approval of LNP-based siRNA and mRNA treatments. Despite clinical advances, significant challenges and knowledge gaps remain in maximizing their efficacy. These …
-
Lipid nanoparticles for delivery of nucleic acid therapeutics
… effective and tolerable lipid nanoparticles (LNPs) for nucleic acid delivery. Specifically, LNP that vary in size, stability and composition were tested for activity after subcutaneous and intravenous injection in order to optimize LNP properties. Furthermore, the incorporation of novel …
-
(Macro)molecular strategies for lipid nanoparticles and T cell engineering
… immense potential of mRNA-lipid nanoparticle (LNP) formulations has become evident, particularly with the emergence of Covid-19 vaccines. The fast, relatively simple, and scalable manufacturing process of mRNA LNP formulations played a crucial role in combatting the global pandemic. This …
-
Biophysical characterization of lipid nanoparticles containing nucleic acid polymers as produced by microfluidic mixing
Lipid nanoparticles (LNP) are currently the most advanced delivery systems for enabling siRNA to be used for therapeutic applications. However, the structure of these siRNA-LNP systems has not been well defined previously. The objective of this thesis is to determine the structure of nucleic …
-
Lipid nanoparticle delivery of small interfering RNA targeting androgen receptor variants for prostate cancer
… the efficacy of a lipid nanoparticle (LNP) carrier of siRNA that specifically targets all AR variant forms (siARv). Two human prostate cancer models were utilized throughout the studies described here: the 22Rv1 cell line exhibits high expression levels of AR splice variants and growth …
Page 1 of 12